Does APIXABAN Cause Off label use? 5,590 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5,590 reports of Off label use have been filed in association with APIXABAN (ELIQUIS). This represents 3.5% of all adverse event reports for APIXABAN.
5,590
Reports of Off label use with APIXABAN
3.5%
of all APIXABAN reports
491
Deaths
1,869
Hospitalizations
How Dangerous Is Off label use From APIXABAN?
Of the 5,590 reports, 491 (8.8%) resulted in death, 1,869 (33.4%) required hospitalization, and 337 (6.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 5,590 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
Adverse event (3,871)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which APIXABAN Alternatives Have Lower Off label use Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ